EP4125887
Notkun á þíenópýridón-afleiðu við meðhöndlun á frílitningsríkjandi belgjanýra (ADPKD)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.4.2021EP published:
7.2.2024EP application number:
21715913.6
EP translation filed:
29.4.2024Grant published:
15.6.2024EPO information:
European Patent Register
Max expiry date:
1.4.2041Expiry date:
1.4.2026Next due date:
30.4.2026
Title in English:
USE OF A THIENOPYRIDONE DERIVATIVE IN THE TREATMENT OF AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)Language of the patent:
English
Timeline
Today
2.4.2021EP application
7.2.2024EP Publication
29.4.2024Translation submitted
15.6.2024Registration published
1.4.2026Expires
Owner
Name:
PoxelAddress:
Immeuble le Sunway 259/261 Avenue Jean Jaures, 69007 Lyon, FR
Inventor
Name:
BOLZE, SébastienAddress:
01600 MASSIEUX, FR
Name:
FOUQUERAY, PascaleAddress:
5643 SINS, CH
Name:
HALLAKOU-BOZEC, SophieAddress:
92160 ANTONY, FR
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
20167687Date:
2.4.2020Country:
EP
Classification
Categories:
A61K 31/4365, A61P 13/12
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 24.4.2024
Expires: 1.4.2025
Payer: Tego IP ehf.
Number: 5
Paid: 28.4.2025
Expires: 1.4.2026
Payer: Árnason Faktor ehf.